Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ICF Announces Timing of First Quarter 2025 Earnings Release and Conference Call
-
Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
Spruce Power Reports Fourth Quarter and Full-Year 2024 Results
-
ESS Tech, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
-
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
-
PepGen Announces Appointment of Two New Directors to its Board
-
VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update
-
Aruna’s Co-Founder and Chief Scientific Officer, Dr. Steven Stice, Inducted into the 2025 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows
-
Aqua Metals Reports Milestone Advancements, Strategic Progress, and Sierra ARC Lithium Battery Recycling Campus Developments in 2024
-
AppLovin to Announce First Quarter 2025 Results
-
Circle Pharma to Present at the Upcoming Investor Conferences
-
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Equity Stock Transfer teams up with Newsmax Inc. for historic IPO opening on New York Stock Exchange’s main board
-
MDB Capital Holdings Provides Fourth Quarter and Full Year 2024 Update
-
Applied Digital Sets Fiscal Third Quarter 2025 Conference Call for Monday, April 14, 2025, at 5:00 p.m. Eastern Time
-
Expion360 Reports Fourth Quarter and Full Year 2024 Financial Results
-
Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma
-
Progress Announces First Quarter 2025 Financial Results
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Allarity Therapeutics Reports Full Year 2024 Financial Results and Provides a Business Update
-
Revolution Medicines to Participate in April 2025 Investor Conferences
-
INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results
-
Mirion Technologies Awarded Contracts for TerraPower Natrium® Reactor Demonstration Project
-
Jack in the Box Inc. Names Lance Tucker as Its Chief Executive Officer
-
Open Lending Announces Leadership Changes
-
Sonim Technologies Reports Full Year 2024 Financial Results
-
ELI ROTH'S THE HORROR SECTION PRESENTS JIMMY AND STIGGS DIRECTED BY JOE BEGOS
-
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
-
Gorilla Technology Exceeds 2024 Expectations with Strong Growth, Profitability and Global Expansion
-
Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results
-
Hearthside Completes Financial Restructuring and Unveils New Maker’s Pride Brand Identity
-
Lumentum and Marvell Showcase Industry’s First Integrated 450G High-Speed Optical Interface at OFC 2025
-
Simply Better Brands Corp. to Present at the LD Micro Invitational XV
-
Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update
-
MGPI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that MGP Ingredients, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ATNM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Actinium Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
EU INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that enCore Energy Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
FLNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fluence Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
APP INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AppLovin Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
MULN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Mullen Automotive, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
EIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Edison International Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
GSK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GSK plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
-
American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Bank OZK Announces Date for First Quarter 2025 Earnings Release and Conference Call
-
Adverum Biotechnologies to Participate in the 2025 RBC Capital Markets Ophthalmology Virtual Conference
-
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
